Korea United Pharm has been accelerated by the passing of the TEVA’s actual inspection inits manufacturingfacilities
The Korea United Pharm’s (executive director Duk-young Kang) completed pharmaceutical product factory has been passed for the actual inspection of TEVA.
Korea United Pharm, in the last February, has made a contract with TEVA, an Israeli multinational pharmaceutical company, to sell its first sel...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
